Associated Papers
Association of CYP2B6 and OPRM1 Genotypes with Methadone Dose Requirements and Serum Concentrations in a Vietnamese Cohorts.
Nguyen QG et al.
Balkan Journal of Medical Genetics : Bjmg, 2025
Severe and prolonged cyclophosphamide-induced hepatotoxicity in a breast cancer patient carrying a CYP2B6*7 variant.
Ming Z et al.
Pharmacogenomics, 2019
Efavirenz Metabolism: Influence of Polymorphic CYP2B6 Variants and Stereochemistry.
Wang PF et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals, 2019
Gene polymorphisms and contents of cytochrome P450s have only limited effects on metabolic activities in human liver microsomes.
Gao N et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences, 2016
PharmGKB summary: Efavirenz pathway, pharmacokinetics.
McDonagh EM et al.
Pharmacogenetics and Genomics, 2015
CYP2B6 gene single-nucleotide polymorphisms in an Italian population sample and relationship with nicotine dependence.
Riccardi LN et al.
Genetic Testing and Molecular Biomarkers, 2015
Allele and genotype frequencies of CYP2B6 in a Turkish population.
Yuce-Artun N et al.
Molecular Biology Reports, 2014
CYP2B6 haplotype and biological factors responsible for hepatotoxicity in HIV-infected patients receiving efavirenz-based antiretroviral therapy.
Manosuthi W et al.
International Journal of Antimicrobial Agents, 2014
Potentially functional SNPs (pfSNPs) as novel genomic predictors of 5-FU response in metastatic colorectal cancer patients.
Wang J et al.
Plos One, 2014
Frequencies of Cytochrome P450 2B6 and 2C8 Allelic Variants in the Mozambican Population.
Arnaldo P et al.
The Malaysian Journal of Medical Sciences : Mjms, 2013
Impact of pharmacogenetic markers of CYP2B6, clinical factors, and drug-drug interaction on efavirenz concentrations in HIV/tuberculosis-coinfected patients.
Manosuthi W et al.
Antimicrobial Agents and Chemotherapy, 2013
Cytochrome P450 variations in different ethnic populations.
McGraw J et al.
Expert Opinion on Drug Metabolism & Toxicology, 2012
The influence of cytochrome oxidase CYP2A6, CYP2B6, and CYP2C9 polymorphisms on the plasma concentrations of valproic acid in epileptic patients.
Tan L et al.
Clinical Neurology and Neurosurgery, 2010
CYP2B6 genotype alters abstinence rates in a bupropion smoking cessation trial.
Lee AM et al.
Biological Psychiatry, 2007
Selective induction of human hepatic cytochromes P450 2B6 and 3A4 by metamizole.
Saussele T et al.
Clinical Pharmacology and Therapeutics, 2007
Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver.
Lang T et al.
Pharmacogenetics, 2001